BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8103063)

  • 1. Reduced CD3-mediated protein tyrosine phosphorylation in anergic CD4+ and CD8+ T cells.
    Bhandoola A; Cho EA; Yui K; Saragovi HU; Greene MI; Quill H
    J Immunol; 1993 Sep; 151(5):2355-67. PubMed ID: 8103063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.
    Arase-Fukushi N; Arase H; Ogasawara K; Good RA; Onoé K
    J Immunol; 1993 Nov; 151(9):4445-54. PubMed ID: 8104995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two separate mechanisms of T cell clonal anergy to Mls-1.
    Yui K; Ishida Y; Katsumata M; Komori S; Chused TM; Abe R
    J Immunol; 1993 Dec; 151(11):6062-75. PubMed ID: 8245451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered protein tyrosine phosphorylation in anergic Th1 cells.
    Cho EA; Riley MP; Sillman AL; Quill H
    J Immunol; 1993 Jul; 151(1):20-8. PubMed ID: 7686931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule.
    van Oers NS; Teh SJ; Garvin AM; Forbush KA; Perlmutter RM; Teh HS
    J Immunol; 1993 Jul; 151(2):777-90. PubMed ID: 8335907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice.
    Blackman MA; Smith HP; Le P; Woodland DL
    J Immunol; 1993 Jul; 151(2):556-65. PubMed ID: 8335899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of T cell clones from an athymic mouse.
    Abromson-Leeman SR; Jayaraman S; Dorf ME
    J Immunol; 1990 Apr; 144(7):2451-8. PubMed ID: 1690767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tyrosine-specific protein phosphorylation in mouse T lymphocyte subsets. Effect of age.
    Shi J; Miller RA
    J Immunol; 1993 Jul; 151(2):730-9. PubMed ID: 8101536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced cell death in proliferating T cells is associated with altered tyrosine phosphorylation of TCR/CD3 subunits.
    Orchansky PL; Teh HS
    J Immunol; 1994 Jul; 153(2):615-22. PubMed ID: 8021499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of activation of murine T cells with bacterial superantigens. In vitro induction of enhanced responses in CD4+ T cells and of anergy in CD8+ T cells.
    Yan XJ; Li XY; Imanishi K; Kumazawa Y; Uchiyama T
    J Immunol; 1993 May; 150(9):3873-81. PubMed ID: 8097227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
    Enk AH; Angeloni VL; Udey MC; Katz SI
    J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo administration of interleukin-2 turns on anergic self-reactive T cells and leads to autoimmune disease.
    Gutierrez-Ramos JC; Moreno de Alboran I; Martínez C
    Eur J Immunol; 1992 Nov; 22(11):2867-72. PubMed ID: 1425912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed allograft rejection by T cell receptor V beta 8.1 transgenic mice peripherally tolerized to Mls-1.
    Bhandoola A; Bassiri H; Markmann JF; Yui K; Hashimoto Y; Greene MI
    Eur J Immunol; 1994 Jul; 24(7):1710-3. PubMed ID: 7913041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
    Scott DE; Kisch WJ; Steinberg AD
    J Immunol; 1993 Jan; 150(2):664-72. PubMed ID: 8419493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
    Herzog WR; Ferreri NR; Ptak W; Askenase PW
    J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin, differentiation, and repertoire selection of CD3+CD4-CD8- thymocytes bearing either alpha beta or gamma delta T cell receptors.
    Suda T; Zlotnik A
    J Immunol; 1993 Jan; 150(2):447-55. PubMed ID: 8419477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.